03.03.2014 Views

How to investigate levels of Adherence to antiretroviral ... - INRUD

How to investigate levels of Adherence to antiretroviral ... - INRUD

How to investigate levels of Adherence to antiretroviral ... - INRUD

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>How</strong> <strong>to</strong> Investigate <strong>Adherence</strong> <strong>to</strong> Antiretroviral Treatment:<br />

An Indica<strong>to</strong>r-Based Approach<br />

Q15. If the manager says a guideline is followed <strong>to</strong> start a patient on ART, then write Y<br />

and name the guideline in the next square. Otherwise write N.<br />

Q16. Ask how many days supply <strong>of</strong> ARVs are usually given <strong>to</strong> patients during their first<br />

month <strong>of</strong> treatment.<br />

Q17<br />

Ask how many days supply <strong>of</strong> ARVs are usually given <strong>to</strong> patients after their first<br />

month <strong>of</strong> treatment.<br />

Q18. Mark Y for all that apply.<br />

Q19. Mark Y for all that apply.<br />

Q20. Answer Y/N—The definition <strong>of</strong> a private space is where a conversation can be had without<br />

being overheard.<br />

Q21-22 Ask whether the programme provides child care, food for patients on ART, and has a<br />

formal system for linking patients with support <strong>of</strong> another person on ART. Answer<br />

each Y/N or S (sometimes).<br />

Q 23<br />

Ask whether the programme has formal links with the community such as churches<br />

or other organizations. Answer Y/N.<br />

Q24-25 Because there are so many different labora<strong>to</strong>ry systems the two questions <strong>to</strong> ask are:<br />

Do you have a functioning labora<strong>to</strong>ry system for measuring CD4 counts, so that<br />

results can be ready for the patient's next routine visit? Answer Y/N.<br />

Is both the test and transport for the test free for patients? Answer Y/N.<br />

The labora<strong>to</strong>ry must be working and active that day. If it is not functioning then it does not<br />

count.<br />

If both Q24 and Q25 are Y, then the indica<strong>to</strong>r <strong>of</strong> whether there is access <strong>to</strong> a labora<strong>to</strong>ry for a<br />

CD4 count will also be Y. Otherwise the indica<strong>to</strong>r will be N.<br />

Q26–28 Remember that the lists <strong>of</strong> medicines need preparing in advance. The ones given here are<br />

only suggestions.<br />

There are three columns for each <strong>of</strong> the three lists <strong>of</strong> drugs. The principles for filling in the<br />

three tables are the same.<br />

The present Y/N column<br />

For the present column, the drugs must be available and in date. It does not matter how<br />

many <strong>of</strong> them there are.<br />

For the number (#) <strong>of</strong> days in s<strong>to</strong>ck in last 90 days column<br />

48

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!